New! - Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01)(PAR-11-107)
Click
here for the NIH program announcement.
Click
here for the ISCC Ancillary Studies Guidelines.
Background
The Intestinal Stem Cell Consortium (ISCC) is a team-science initiative
established by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious
Diseases (NIAID) in 2009. The ISCC is governed by a Steering Committee (SC) to coordinate
and facilitate research activities for the overall program and
to ensure synergy and efficiency. Click
here
to view the ISCC Organizational Chart.
Mission Statement and Goals
The mission of the ISCC is to advance the understanding of intestinal
epithelial stem cell biology during development, homeostasis, regeneration
and disease. The immediate goals of the ISCC are to isolate, characterize,
culture and validate populations of intestinal stem cells; answer major
questions in stem cell biology of the intestinal epithelium; and accelerate
research by making information and resources available to the research community.
Long-term goals include: 1) laying the ground work for therapeutic manipulation
of the intestinal epithelium 2) contributing to the greater understanding of
stem cell biology through knowledge of the intestine as a model stem cell-driven system.